Drug
Purinostat clinical trials
Includes 2 studies of Purinostat mesylate.
Keep track of what changes. Save the purinostat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStudies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses purinostat is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell LymphomaRecruitingPhase 3Chengdu Zenitar Biomedical Technology Co., LtdNCT07011056Written as Purinostat Mesylate for Injection
- Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaRecruitingPhase 1/2Chengdu Zenitar Biomedical Technology Co., LtdNCT06484829Written as Purinostat Mesylate 4 mg/m2
- Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominantCompletedPhase 1Chengdu Zenitar Biomedical Technology Co., LtdNCT05526313Written as Purinostat Mesylate 1.2mg/m^2
Codes
What other systems call purinostat · ClinicalTrials.gg INT016594
- UNII (FDA) FTV8V4AYQ8PURINOSTATOne source FDA
- NCI Thesaurus C192176PurinostatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | FTV8V4AYQ8 | PURINOSTAT | One source FDA |
| NCI Thesaurus | C192176 | Purinostat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.